DOCSLIB.ORG

Diretoria De Patentes

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Diretoria De Patentes PATENTES, DESENHOS INDUSTRIAIS, CONTRATOS, PROGRAMAS DE COMPUTADOR, INDICAÇÕES GEOGRÁFICAS o REVISTA DA PROPRIEDADE INDUSTRIAL N 1991 03 de Março de 2009 SEÇÃO I REPÚBLICA FEDERATIVA DO BRASIL Presidente Luís Inácio Lula da Silva MINISTÉRIO DO DESENVOLVIMENTO, INDÚSTRIA E COMÉRCIO EXTERIOR Ministro do Desenvolvimento, Indústria e Comércio Exterior Miguel João Jorge Filho INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL PRESIDENTE PARANÁ Jorge de Paula Costa Ávila Chefe: Renee Fernando Senger Pernambuco Rua Marechal Deodoro, 344, 16º andar Universitária Federal de Pernambuco - UFPE VICE-PRESIDENTE Ademir Tardelli Edifício Atalaia, Centro, Curitiba - PR Av. Prof. Moraes Rego, 1235 – Campus Universitário CEP: 80010-909 Bairro - Engenho do Meio CHEFE DE GABINETE Telefone/Fax: (0XX-41) 3322-4411 Recife - PE - CEP: 50670-920 Josefina Sales de Oliveira RIO GRANDE DO SUL Tel/Fax:(0XX-81) 3453-8145 e 3271-1223 Chefe: Vera Lúcia de Seixas Grimberg Piauí DIRETORIA DE ARTICULAÇÃO E INFORMAÇÃO TECNOLÓGICA Rua Sete de Setembro, 515 – 5º andar - Centro Av. João XXIII, n° 865 Marco Antônio Lima Porto Alegre - RS - CEP: 90010-190 Espaço Cidadania Telefone/Fax.: (0XX-51) 3226-6909 e 3226-6422 Teresina - PI - CEP: 64049-010 PROCURADORIA GERAL SÃO PAULO Tel.:(0XX-86) 3235-9616/3218-1838 Mauro Sodré Maia Chefe: Maria dos Anjos Marques Buso Fax:(0XX-86) 3218-1838 DIRETORIA DE PATENTES Rua Tabapuã, 41 - 4º andar - Itaim-Bibi Rio Grande do Norte Carlos Pazos Rodrigues São Paulo - SP - CEP: 04533-010 SECRETÁRIA DO DESENVOLVIMENTO ECONÔMICO – DIRETORIA DE MARCAS Telefone/Fax: (0XX-11) 3071-3434 SEDEC BR 101 - Km 0 - 1 º andar - Lagoa Nova Terezinha de Jesus Guimarães Natal - RN - CEP: 59064-901 DIRETORIA DE TRANSFERÊNCIA DE TECNOLOGIA REPRESENTAÇÕES: Tel.: (0XX-84) 3232-1724 Breno Bello de Almeida Neves Acre Fax:(0XX-84) 3232-1745 DIRETORIA DE ADMINISTRAÇÃO E SERVIÇOS SECRETARIA DE ESTADO DE PLANEJAMENTO E Rondônia Julio Cesar Dutra De Oliveira DESENVOLVIMENTO SUSTENTÁVEL GERÊNCIA DE Rua Sete de Setembro, 830 – Centro Shopping Cidadão MARCAS E PATENTES REVISTA DA PROPRIEDADE INDUSTRIAL Porto Velho – RO – Cep: 78900-00 Rua Marechal Deodoro, 219 – 4º andar - Centro Tel.:(0XX-69) 3216-1031 e 3216-8636 Órgão Oficial do INSTITUTO NACIONAL DA Rio Branco - AC - CEP: 69.900-210 Fax: (0XX-69) 3216-1000 PROPRIEDADE INDUSTRIAL Tel./FAX : (0XX-68) 3229-4259 e 3229-6349 Roraima Lei nº 5648, de 11.12.70 art. 9º e decreto nº 68.104, de Alagoas JUNTA COMERCIAL DO ESTADO DE RORAIMA 22.01.71, art. 24 SECRETARIA DA INDUSTRIA E COM.SERVIÇO Av. Jaime Brasil, 157 - Centro Av. Da Paz, N.1108 - Centro Para adquirir RPI’s antigas o usuário deve entrar em Boa Vista - RR - CEP: 69.301-350 Jaranguá - Maceió - AL - CEP: 57022-005 contato com o SAP – Setor de Assinatura, localizado no Tel.: (0XX-95) 3224-9777, 3623-1220 e 3623-2437 Tel.: (0XX-82) 3315-721, 3315-1719 térreo da sede do INPI. Telefone: (0XX-21) 2139-3422 Fax.: (0XX-95) 623-2171 Amapá SANTA CATARINA SEDE DO INPI JUNTA COMERCIAL SECRETARIA DE DESENVOLVIMENTO ECONÔMICO E Av. FAB, 1610 – Centro - Macapá - AP - CEP: 68900-000 INTEGRAÇÃO AO MERCOSUL Praça Mauá nº 7 - Centro Tel.: (0XX-96) 3222-4867 Ramal 230 e 3222-4866 Av. Rio Branco, 387 / - Centro Rio de Janeiro - RJ - CEP: 20083-900 Fax: (0XX-96) 3222-3598 Florianópolis - SC - CEP: 88015-200 Tel.: PABX (0XX-21) 2139-3000 Amazonas Tel.: (0XX-48) 3223-5227/4827 Fax: INPI (0XX-21) 2263-2539 Rua Major Gabriel, n° 1870 – Praça 14 - Manaus – AM Fax.: (0XX-48) 3223-4827 PROC/DICONS CEP: 69020-060 Sergipe Tel.: (0XX-21) 2139-3731, 2139-3732 Tel.: (0XX-92) 2126-1235 e 2126-1200 Av. Tancredo Neves, n° 5.500 – Bairro América – Aracajú Fax: (0XX-21) 2253-9841 BAHIA – Sergipe – Cep: 49080-480 DIRMA - Diretoria de Marcas Rua Pedro R. Bandeira, 143 – 5º andar Tel/Fax – (79) 2106-7751 e 2106-7700 Diretoria... 10º andar Cidade Baixa – Salvador – Bahia Tocantins Tel.: (0XX-21) 2139-3758, 2139-3104, 2139-3214 CEP: 40015-080 SECRETARIA DE INDÚSTRIA, COMÉRCIO E TURISMO Fax: (0XX-21) 2139-3528 Tel.: (0XX-71)3326-9597 / 3242-5223 DO ESTADO DO TOCANTINS Central de atendimento: (0XX-21) 2139-3158 Fax.: (0XX-71) 242-5223 Praça dos Girassóis, snº - Marco Zero DIRPA - Diretoria de Patentes Espírito Santo Palmas - TO - CEP: 77003-900 Diretoria... 10º andar Rua Abigail do Amaral Carneiro, 191 Tel.: (0XX-63) 3218-2002, 218-2000 Tel.: (0XX-21) 2139-3592 e 2233-0785 Edifício Arábica – 3° andar – salas 312, 314 e 316 Fax: (0XX-63) 3218-2090 Fax: (0XX-21) 2139-3194 Enseada do Suá - Vitória - ES - CEP: 299055-907 DIRTEC - Diretoria de Transferência de Tecnologia Tel.: (0XX-27) 3235-7788 e 3315-9823 Esta Publicação é de responsabilidade da Coordenação Diretoria... 10º andar Goiás Geral Modernização e Informática Tel.: (0XX-21) 2139-3608, 2139-3648, 2139-3651 JUNTA COMERCIAL DO ESTADO DE GOIÁS Telefone: (21) 2139-3447 Fax: (0XX-21) 2253-0430 Rua 260 - Esquina 259 - Setor Universitário, Quadra 84/A DART - Diretoria de Articulação e Informação Tecnológica CEP:74610.310 Goiânia -GO Diretoria 10º andar Tel.: (0XX-62) 3202-2246 Tel.: (0XX-21) 2139-3354 Maranhão Fax: (0XX-21) 2233-5077 SUBDELEGACIA DE INDÚSTRIA E COMÉRCIO REPRESENTAÇÕES DO INPI NOS OUTROS ESTADOS Av. Carlos Cunha s/n°, Edifício Nagib Haickel – 1° andar DIVISÕES REGIONAIS Bairro Calhau - MA - CEP: 65065-180 Telefone/Fax: (0XX-98) 3218-9208 – 3218-9226 BRASÍLIA Mato Grosso Chefe: Antonio Carlos Pereira Coelho INMETRO/MT SAS - Quadra 2, Lote 1/A Rua Historiador Rubens de Mendonça, s/nº - CPA Brasília - DF - CEP: 70040-020 Cuiabá - MT - CEP: 78055-500 Tel. : (0XX-61) 224-1114 Tel.: (0XX-66) 3644-3095 Fax.: (0XX-61) 323-2520 Fax: (0XX-66) 3644-2902 CEARÁ Mato Grosso do Sul Chefe: Ary Gadelha de Alencar Araripe SECRETARIA DE TURISMO, INDÚSTRIA E COMÉRCIO Rua Doutor Mário Martins Coelho, nº 36 Junta Comercial/MS Aldeota - Fortaleza - CE - CEP: 60170-280 Rua Dr. Arthur Jorge, 1376 - Centro Tel.: (0XX-85) 3261-1372 e 3261-1695 Campo Grande - MS - CEP: 79010-210 Fax: (0XX-85) 3268-1495 Tel.: (0XX-67) 3316-4429 MINAS GERAIS Pará Chefe: Rafael Jardim Goulart de Andrade SEDE DA SECRETARIA DE ESTADO INDÚSTRIA, Avenida Amazonas nº 1.909 COMÉRCIO E MINERAÇÃO - SEICOM Santo Agostinho - Belo Horizonte - MG - CEP: 30180-002 Av. Presidente Vargas, 1020 Tel.: (0XX-31) 3291-5614 CEP: 66060-670 – Centro - Belém - PA Fax: (0XX-31) 3291-5449 Tel.: (0XX-91) 3217-5889 Fax: (0XX-91) 3217-5840 Paraíba Rua Feliciano Cisne n° 50 – Bairro Jaguaribe João Pessoa/PB - CEP: 58015-570 Tel./FAX(0XX-83) 3208-3922 - 3208-3923 e 3242- 2545/2729 Postos Avançados RPI 1991 de 03/03/2009 POSTOS AVANÇADOS – RIO DE JANEIRO POSTO AVANÇADO SANTARÉM / PA POSTOS AVANÇADOS – EM MINAS GERAIS CABO FRIO SANTARÉM JUIZ DE FORA ACIACF SEFA – Secretaria Estadual da Fazenda UNIVERSIDADE FEDERAL DE JUIZ DE FORA Rua Bento José Ribeiro, 18, 3º andar Av. Mendonça Furtado, 2797 – Bairro Fátima CRITT – CENTRO REGIONAL DE INOVAÇÃO E CEP: 28905-090 Santarém - Pará TRANSFERÊNCIA DE TECNOLOGIA Tel.: (0XX-24)2647-6333 CEP.: 68005-020 CAMPUS UNIVERSITÁRIO Tel.: (0XX-91) 523-2632 SÃO PEDRO CAMPOS CEP.: 36036-330 ACIC Tel.: (0XX-32)3229-3435 e 3229-3477 Praça São Salvador,41 , 16º andar Fax: (0XX-32)3229-3479 CEP: 28010-000 POSTO AVANÇADO SALVADOR / BA Tel.: (0XX-22) 2723-5174 PATROCÍNIO ACIP – ASSOCIAÇÃO COMERCIAL INDUSTRIAL DE NOVA FRIBURGO SALVADOR PATROCÍNIO ACINF SAC-EMPRESARIAL Rua Joaquim Carlos dos Santos, nº 141 – Cidade Jardim Av. Alberto Braune, nº111 , Térreo Av. Otávio Mangabeira, n° 6929 – Multishop Boca do Rio – CEP.: 38740-000 CEP:28613-001 Bairro Boda do Rio Tel.: (0XX-34) 3831-5500 Tel.: (0XX-22) 2522-1145 e 2522-8452 CEP.:41715-000 Tel.:(0XX-71) 281-4148 PETRÓPOLIS ASSOCIAÇÃO COMERCIAL EMPRESARIAL DE POSTO AVANÇADO RIO VERDE / GO PETRÓPOLIS Rua Irmãos D’Angelo nº 48 – 7º andar CEP: 25685-330 RIO VERDE Telefone/Fax (0XX-24) 237-1101 JCIRV Rua Augusta Bastos, 479 – Centro VOLTA REDONDA CEP.: 75900-000 ACIAVR Tel.: (0XX-64)3621-1985 Rua Assis Chateaubriand, nº 18 – Aterrado Fax: (0XX-64) 3613-1569 Volta Redonda - CEP: 27295-210 Telefone: (0XX-24) 3346-5332 Fax: (0XX-24)3347-2999 POSTOS AVANÇADOS - SANTA CATARINA CHAPECÓ ASSOCIAÇÃO COMERCIAL E INDUSTRIAL DE CHAPECÓ Av. Getúlio Vargas, 1748 - Centro CEP: 89805-100 Tel.: (0XX-49) 7323-4100 Fax.: (0XX-49) 7323-1723 JOINVILLE ASSOCIAÇÃO COMERCIAL E INDUSTRIAL DE JOINVILLE Rua do Príncipe, 330,10º andar CEP: 89200-000 Tel.: (0XX-47) 461-3364 RIO DO SUL ASSOCIAÇÃO COMERCIAL E INDUSTRIAL Rua XV de Novembro, 73 – s/174 - Centro Caixa Postal: 174 - CEP: 89290-000 Tel./Fax: (0XX-47) 821-3857 XANXERÊ ASSOCIAÇÃO COMERCIAL E INDUSTRIAL Av. Brasil, 260 - 5º andar - Edifícil Tiradentes Caixa Postal: 241 - CEP: 89820-000 Tel./Fax: (0XX-49)433-0420 Comunicados RPI 1991 de 03/03/2009 Comunicados 5 Ministério do Desenvolvimento, Indústria e Comércio Exterior - Presidência do INPI 9 DIRETORIA DE PATENTES Pedidos de Patentes não anuídos pela ANVISA 11 Exame Formal Preliminar – Índice Remissivo por Depositante - Exame Formal Preliminar – Índice Numérico Remissivo - Exigências Decorrentes do Exame Formal Preliminar - Tabela de Códigos de Despachos e Códigos INID de Pedidos, Patentes (incluindo as de MI/DI expedidas na vigência da Lei 5772/71) e Certificados de Adição de Invenção 13 Tabela de Códigos de Despachos de Pedidos e Patentes (incluindo as de MI/DI expedidas na vigência da Lei 5772/71) - Período de Transição (Lei 5772/71) 19 Índice Numérico Remissivo de Pedidos, Patentes e Certificados de Adição de Invenção 21 Notificação - Fase Nacional - PCT e Publicação de Pedidos de Patente e de Certificado de Adição de Invenção 25 Despachos Relativos a Pedidos, Patentes (incluindo
Load more

Recommended publications
  • Federal Register/Vol. 70, No. 141/Monday, July 25, 2005/Notices
    42546 Federal Register / Vol. 70, No. 141 / Monday, July 25, 2005 / Notices awpetition.htm/. In addition, an docket. When a document is selected FEDERAL TRADE COMMISSION electronic version of the public docket from the index list in EPA Dockets, the is available through EPA’s electronic system will identify whether the Granting of Request for Early public docket and comment system, document is available for viewing in Termination of the Waiting Period EPA Dockets. You may use EPA Dockets EPA’s electronic public docket. Under the Premerger Notification rules at http://www.epa.gov/edocket/ to Although not all docket materials may submit or view public comments, access be available electronically, you may still Section 7A of the Clayton Act, 15 the index listing of the contents of the access any of the publicly available U.S.C. 18a, as added by Title II of the official public docket, and to access docket materials through the docket Hart-Scott-Rodino Antitrust those documents in the public docket facility identified in Unit I.B.1. EPA Improvements Act of 1976, requires that are available electronically. intends to work towards providing persons contemplating certain mergers Although not all docket materials may electronic access to all of the publicly or acquisitions to give the Federal Trade be available electronically, you may still available docket materials through Commission and the Assistant Attorney access any of the publicly available EPA’s electronic public docket. General advance notice and to wait docket materials through the docket II. What Action is the Agency Taking? designated periods before facility identified in Unit I.B.1.
    [Show full text]
  • Patentes, Desenhos Industriais, Contratos, Programas De Computador, Indicações Geográficas, Topografia De Circuito Integrado
    PATENTES, DESENHOS INDUSTRIAIS, CONTRATOS, PROGRAMAS DE COMPUTADOR, INDICAÇÕES GEOGRÁFICAS, TOPOGRAFIA DE CIRCUITO INTEGRADO o REVISTA DA PROPRIEDADE INDUSTRIAL N 2152 03 de Abril de 2012 SEÇÃO I REPÚBLICA FEDERATIVA DO BRASIL Presidente Dilma Roussef MINISTÉRIO DO DESENVOLVIMENTO, INDÚSTRIA E COMÉRCIO EXTERIOR Ministro do Desenvolvimento, Indústria e Comércio Exterior Fernando Pimentel INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL PRESIDENTE Fax: (31) 3291-5449 Tel.: (27) 3235-7788 Jorge de Paula Costa Ávila Horário de Atendimento: 10h às 16h30 Fax: (27) 3315-9823 Horário de Atendimento: 10h às 16h30 VICE-PRESIDENTE Ademir Tardelli PARANÁ Chefe: Renee Fernando Senger CHEFE DE GABINETE e-mail: [email protected] Goiás Josefina Sales de Oliveira Rua Marechal Deodoro, 344, 16º andar Responsável: Rosemar Rodrigues de Oliveira Marinari Edifício Atalaia, Centro, Curitiba - PR JUNTA COMERCIAL DO ESTADO DE GOIÁS DIRETORIA DE COOPERAÇÃO PARA O Rua 206 - Esquina 259 - Setor Universitário, Quadra 84, Lt. DESENVOLVIMENTO CEP: 80010-909 Denise Nogueira Gregory Telefone: (41) 3322-4411 5 à 8 Goiânia – GO CEP:74640-310 Horário de Atendimento: 10h às 16h30 Tel.: (62) 3202-2246, 3202-2262, 3261-4833 Ramal: 279 PROCURADORIA FEDERAL no INPI Horário de Atendimento: 8h às 18h Mauro Sodré Maia RIO GRANDE DO SUL DIRETORIA DE PATENTES Chefe: Maria Isabel de Toledo Andrade Cunha Maranhão Julio César Castelo Branco Reis Moreira e-mail: [email protected] Responsável: Déa Lourdes Furtado de Oliveira Secretaria de Estado da Indústria e Comércio DIRETORIA DE MARCAS e-mail: [email protected] Vinicius Bogéa Câmara Av. José de Alencar, 521 – Cobertura 902 – Bairro Menino Av. Carlos Cunha s/n° - sala 210 Jesus.
    [Show full text]
  • SCHEDULE 14A (RULE 14A-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(A) of the Securities Exchange Act of 1934 (Amendment No
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant È Filed by a Party other than the Registrant ‘ Check the appropriate box: ‘ Preliminary Proxy Statement. ‘ Confidential, for use of the Commission Only (as permitted by Rule 14a-6(e)(2)). È Definitive Proxy Statement. ‘ Definitive Additional Materials. ‘ Soliciting Material Pursuant to §240.14a-12. pSivida Corp. (Name of Registrant as Specified in its Charter) (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) Payment of Filing Fee (Check the appropriate box): È No fee required. ‘ Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction applies: (2) Aggregate number of securities to which transaction applies: (3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): (4) Proposed maximum aggregate value of transaction: (5) Total fee paid: ‘ Fee paid previously with preliminary materials. ‘ Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. (1) Amount Previously Paid: (2) Form, Schedule or Registration Statement No.: (3) Filing Party: (4) Date Filed: 400 Pleasant Street Watertown, MA 02472 United States October 25, 2012 Dear Fellow Stockholders, It is our pleasure to invite you to this year’s Annual Meeting, which will be held on December 14, 2012 at 10:00 a.m.
    [Show full text]
  • The Influence of Organizational Capacity and Environmental Dynamism on the First Move–Performance Relationship Vera L
    Florida State University Libraries Electronic Theses, Treatises and Dissertations The Graduate School 2006 The Influence of Organizational Capacity and Environmental Dynamism on the First Move–Performance Relationship Vera L. Street Follow this and additional works at the FSU Digital Library. For more information, please contact [email protected] THE FLORIDA STATE UNIVERSITY COLLEGE OF BUSINESS THE INFLUENCE OF ORGANIZATIONAL CAPACITY AND ENVIRONMENTAL DYNAMISM ON THE FIRST MOVE–PERFORMANCE RELATIONSHIP By VERA L. STREET A Dissertation submitted to the Department of Management in partial fulfillment of the requirements for the degree of Doctor of Philosophy Degree Awarded: Fall Semester, 2006 The members of the Committee approve the dissertation of Vera L. Street defended on August 8, 2006. _______________________________ Bruce T. Lamont Professor Directing Dissertation _______________________________ Susan S. Fiorito Outside Committee Member _______________________________ Jack Fiorito Committee Member _______________________________ K. Michele Kacmar Committee Member _______________________________ Pamela L. Perrewé Committee Member Approved: _____________________________ Caryn Beck-Dudley Dean, College of Business The Office of Graduate Studies has verified and approved the above named committee members. ii This dissertation is dedicated to my husband, my teacher, my inspiration, and my best friend, Marc D. Street. iii ACKNOWLEDGEMENTS I would like to thank my dissertation chair, Bruce Lamont, for taking me under his wing and believing in me. Many thanks go to my other committee members as well. Thanks to Micki Kacmar for all the knowledge and advice you imparted to me both in and out of class, thanks for your constant support, and thanks for staying with me across the miles. Thanks to Pam Perrewé for your insights and for always helping me to keep things in perspective.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2012/0157420 A1 Schneider (43) Pub
    US 2012O157420A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2012/0157420 A1 Schneider (43) Pub. Date: Jun. 21, 2012 (54) TREATMENT AND PREVENTION OF A 6LX 3L/505 (2006.01) SECONDARY INTURY AFTER TRAUMA OR A6IP 29/00 (2006.01) DAMAGE TO THE CENTRAL NERVOUS A6II 3/47 (2006.01) SYSTEM A6IP 25/00 (2006.01) A6IP3/06 (2006.01) (76) Inventor: Eric B Schneider, Glen Arm, MD A6IP 9/00 (2006.01) (US) A6IP 25/22 (2006.01) A6IP 25/24 (2006.01) (21) Appl. No.: 13/392,371 A63L/366 (2006.01) A6II 3/40 (2006.01) (22) PCT Filed: Aug. 31, 2010 (52) U.S. Cl. ......... 514/171; 514/460, 514/419:514/510; (86). PCT No.: PCT/US 10/472O6 514/277; 514/275: 514/423: 514/311 S371 (c)(1), (57) ABSTRACT (2), (4) Date: Feb. 24, 2012 A method of administering one or multiple medications to human patients with CNS injury through oral or parenteral Related U.S. Application Data (including transdermal, intravenous, Subcutaneous, intra (60) Provisional application No. 61/238,453, filed on Aug. muscular) routes. Inflammatory and immunological pro 31, 2009. cesses have been shown to cause secondary damage to CNS s tissues in individuals with acute CNS injury. The present O O invention administers one or more of the following medica Publication Classification tions, which have properties that mitigate the inflammatory (51) Int. Cl. and immunological processes that lead to secondary CNS A6 IK3I/56 (2006.01) damage, via trans-dermal absorption: a statin compound A6 IK 3/405 (2006.01) (e.g., a HMG-CoA reductase inhibitor), a progesterone com A6 IK 3L/25 (2006.01) pound, or a cholinesterase inhibiting compound, among oth A6 IK 3/448 (2006.01) ers, either alone or in combination with other compounds.
    [Show full text]
  • UR-Coeus Sponsor List
    UR-Coeus Sponsor Table (alphabetical by sponsor name) Sponsor Sponsor Code Sponsor Type 2138 21st Century Medicine CORP Sponsor Type Key 1 3M CORP CORP = Corporate 3803 4S3 Bioscience Inc CORP FED = Federal 5207 A. F. Associates Family Medicine ONFA FND = Foundation 2602 A. P. Pharma CORP IND = Individuals 2 A.L. Mailman Foundation FND NYS = New York State 2023 AA Implant Dentistry Research Foundation ONFA OLG = Other Local Gov't 3 AAA Fnd for Traffic Safety ONFA ONFA = Other Non-Fed Agency 2329 aaiPharma Inc CORP VHA = Voluntary Health Agency 3257 Aamjiwnaang First Nations Community ONFA 5345 Aarhus University Hospital ONFA 3713 Aaron Copland Fund for Music, Inc. ONFA 4 AARP Andrus Fdn FND 3853 AB Sciences CORP 3378 AB Vector, Inc CORP 899 Abbott Diagnostics CORP 3864 Abbott Fund FND 14 Abbott Laboratories CORP 5126 AbbVie, Inc. CORP 5854 Abeona Therapeutics CORP 5063 Abington Medical Specialists ONFA 5331 Abington Memorial Hospital ONFA 2835 ABIOMED, Inc. CORP 3687 Ablation Frontiers CORP 5118 Ablynx NV CORP 2053 ABMRF/Fnd for Alcohol Research ONFA 2171 Abortion Rights Mobilization ONFA 3361 Abraxix BioScience, LLC CORP 4953 Abt Associates, Inc. CORP 5037 Academic Gastrointestinal Cancer Consortium ONFA 15 Academic Med Ctr Cons ONFA 3733 Academic Pediatric Association ONFA 3160 Academy of Orofacial Pain ONFA 2122 Academy of Prosthodontics Foundation ONFA 3663 Acadia Pharmaceuticals, Inc. CORP 3273 Accelerate Brain Cancer Cure ONFA 5584 Acceleron Pharma Inc. CORP 5601 Accelovance, Inc. CORP 5940 Accreditation Council Grad Med Educ ONFA 5832 Accriva Diagnostics CORP 3888 AccuGenomics, Inc. CORP 5656 Acerta Pharma CORP 6101 Acessa Health, Inc.
    [Show full text]
  • Biotechnology and Drug Discovery: from Bench to Bedside
    Original Article Biotechnology and Drug Discovery: From Bench to Bedside Yoav Avidor, MD, MBA, Nicola J. Mabjeesh, MD, PHD, and Haim Matzkin, MD are taking center stage. Small-molecule drug (SMD) discov- Abstract: New biotechnology and drug discovery technologies are ery, which uses and builds on organic molecules as starting facilitating the rapid expansion of the clinical drug chest, empow- materials, is also benefiting from the input of newer technol- ering clinicians with a better understanding of disease as well as ogies such as combinatorial chemistry and high-throughput novel modalities for treating patients. Important research tools and screening. themes include genomics, proteomics, ligand-receptor interaction, Although many physicians are not exposed to biotech- signal transduction, rational drug design, biochips, and microarrays. nology, we think that it is valuable for clinicians to gain some Emerging drug classes include monoclonal antibodies, cancer vac- fluency in the important trends in this field because the fruits cines, gene therapy, antisense strands, enzymes, and proteins. In this of biotechnological research are reaching the clinic. The speed article, we review these topics and illustrate their potential impact by of events that are occurring in biotechnology is breathtaking presenting an overview of promising drugs in the pipeline. Clini- and inspiring indeed. The younger generation of physicians cians who use these novel treatments must become familiar with has had the privilege of studying molecular biology as med- these trends. ical students. Even those physicians who did study molecular Key Words: biotechnology, drug classes, drug development biology in medical school, however, must be excited but somewhat bewildered and uncomfortable about the advent of novel treatment modalities involving the use of antisense iotechnology is introducing new capabilities to drug dis- strands and monoclonal antibodies (MAb).
    [Show full text]
  • FOIA Request & Response
    •••••••••••••••• ••••••••••••••• ••••••••••••••• ••••••••••••••• Sec tilis RECEIVE~ FOIA / PA Officer John Livornese JUN l2 2018 U.S. Securities & Exchange Commission FOIA Office Office of 100 F Street NE, Mail Stop 5100 Ff°'' ... - - Washington, DC 20549 June 12, 2018 Dear Mr. Livornese: I request pursuant to the Freedom of Information Act (FOIA) 5 U.S.C. § 552. As Amended by Public Law No. 104-231,110 Stat. 3048, copies of the following agreements: Exhibit 10.6 to Form S-1/A filed on 10/02/2003 by Aderis Pharmaceuticals Inc Exhibit Title: Exclusive License Agreement CIK: 1164722 Sectilis will pay up to $61 for research, copies and review fees for all of the abovementioned agreements. Please forward all releasable material for copying. My daytime telephone number is 202-798-8809. Please call me or e-mail at [email protected] to discuss the total cost or estimated cost of this research/copies should the amount exceed the price indicated in this request. Sincerely, Stella Vasconcellos Research Assistant Sectilis LLC 6931 Arlington Rd. # 580 Bethesda, MD 20814 14 UNITED STATES SECURITIES AND EXCHANGE COMMISSION STATION PLACE 100 F STREET, NE WASHINGTON, DC 20549-2465 Office of FOIA Services July 09, 2018 Ms. Stella Vasconcellos Sectilis LLC 6931 Arlington Rd. # 580 Bethesda, MD 20814 RE: Freedom of Information Act (FOIA), 5 U.S.C. § 552 Request No. 18-04766-E Dear Ms. Vasconcellos: This letter is in response to your request, dated and received in this office on June 12, 2018, for information regarding Exhibit 10.6 to Form S-1/A filed on October 2, 2003 filed by Aderis Pharmaceuticals, Inc.
    [Show full text]
  • SCHEDULE 14A (RULE 14A-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(A) of the Securities Exchange Act of 1934 (Amendment No
    Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement. ☐ Confidential, for use of the Commission Only (as permitted by Rule 14a-6(e)(2)). ☐ Definitive Proxy Statement. ☐ Definitive Additional Materials. ☐ Soliciting Material Pursuant to §240.14a-12. pSivida Corp. (Name of Registrant as Specified in its Charter) (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) Payment of Filing Fee (Check the appropriate box): ☒ No fee required. ☐ Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction applies: (2) Aggregate number of securities to which transaction applies: (3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): (4) Proposed maximum aggregate value of transaction: (5) Total fee paid: ☐ Fee paid previously with preliminary materials. ☐ Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. (1) Amount Previously Paid: (2) Form, Schedule or Registration Statement No.: (3) Filing Party: (4) Date Filed: Table of Contents 480 Pleasant Street Watertown, MA 02472 United States October 26, 2015 Dear Fellow Stockholders, It is our pleasure to invite you to this year’s Annual Meeting, which will be held on December 3, 2015 at 10:00 a.m.
    [Show full text]
  • Academy Centennial Fund Academy Funds Acon Investments
    Acon Investments / Newbridge Academy Centennial Fund Andean Partners P.O. Box 110367 1133 Connecticut Avenue, NW, Suite 700 Research Triangle Park, NC 27609-0367 Washington, DC 20036 Ph: 919-933-3100 Ph: 202-454-1100 Fax: 202-454-1101 Web: www.academyfunds.com Email: [email protected] Company Contacts: Company Contacts: Ginns, Jonathan J. Managing Director Kline, Glenn J. [email protected] Senior Managing Director [email protected] Aronson, Bernard Partner Clannamea, John Senior Managing Director [email protected] Adams Street Partners LLC Caplice, Matt Senior Analyst One North Wacker Drive Suite 2200 [email protected] Chicago, IL 60606-2807 Ph: 312-553-7890 Fax: 312-553-7891 Brooks, Thomas Web: www.adamsstreetpartners.com Partner Email: [email protected] Johnson, Gregory Company Contacts: French, Bon Biotechnology Portfolio: Chief Executive Officer and Chief Investment Officer Biolex Inc.; Pilot Biotechnologies Inc.; VetXcel; Taylor, Craig Xanthon Inc.; Zymotech Partner Stages Funded: Gould, Terry Partner Series A-B Biotechnology Portfolio: Academy Funds Aviron Inc.; BioTransplant Inc.; CardioVention Inc.; CombiChem Inc.; CombinatoRx Inc.; DepoTech 111 North Chestnut Street, Suite 105 Corporation; Eligix Inc.; FemRx Inc.; Galileo Winston-Salem, NC 27101 Laboratories Inc.; Heartport Inc.; Instrumentation Ph: 336-748-9991 Fax: 336-748-9909 Metrics Inc.; IntraBiotics Pharmaceuticals Inc.; Web: www.academyfunds.com Pharmacyclics Inc.; Myogen Inc.; NxStage Medical Inc.; Email: [email protected] Pharmacyclics
    [Show full text]
  • Colleges and Universities, Teaching Hospitals, and Biotechnology Companies
    Colleges and Universities, Teaching Hospitals, and Biotechnology Companies Central Region : Marked by an outstanding workforce, a strong concentration of colleges and universities, lower cost R&D, manufacturing and incubator space, and regional commitment to the growth of the biotechnology industry : Distinguished life science companies and institutions including: Bristol-Myers Squibb, Abbott, Cytec, AstraZeneca, WPI, UMass Medical School, and others !( !( !( Western Region !( : Offers the lowest business and development costs in the state !( !( !( !!(!( Berkshire County is known as America’s Premier Cultural Resort, !(!(!(!(!(!( spawning a creative economy to join its traditional industries !( !( !(!( !( !( !( !( : Distinguished life science companies and institutions including !( !(!(!( !( !(! Bay State Medical Center, Nuclea Biomarkers, MicroTest, Tyco !( !( !( !(!( !( !( ! !( !( !( Healthcare, UMass Amherst, Williams College, Amherst College, !( !( ! !(!( !(!( !( !( !( !( !( !( !( !(!(!( !( !( and others !( !( !( !( !(!( !( !( !( !( !( : UMass and Baystate Medical Center have formed a free-standing ! !( !(!( !( !( !(!( !( !(!(!( !(!( !( !( !( !( !(!( !( !( !( Biomedical Research Institute !( !( !(!(!(!( !( !(!(!( !(!(!(!(!( !( !( !(! !(!( !( !( !(!( !( !(!( !( !( !(!( Northeast Region !(!(!( !( !(!( !( !( !(!( !(!( !( !( !( !(!(!(!( !(!(!(!( !( !(!( !(!(!( !(!(!(!( !( : Region includes the Merrimack Valley-I-495, north-south Route 3, !( !(!(!( !(!(!(!( !(!(!(!(!((! !(!(!(!( !( !( !(!( !( !(!(!(!(!(!(!(!(!(!(!(!(!(!(!( !(!( !( !( !(!(!(
    [Show full text]
  • List of Section 13F Securities, Second Quarter 2002
    OFFICIAL LIST OF SECTION 13(F) SECURITIES USER INFORMATION SHEET General This list of "Section 13(f) securities" as defined by Rule 13f-1(c) [I7 CFR 240.1 3f-I (c)] is made available to the public pursuant to Section13 (f) (3) of the Securities Exchange Act of 1934 [15 USC 78m(f) (3)]. It is made available for use in the preparation of reports filed with the Securities and Exhange Commission pursuant to Rule 13f-1 [I7 CFR 240.1 3f-11 under Section 13(f) of the Securities Exchange Act of 1934. An updated list is published on a quarterly basis. This list is current as of June,lS, 2002, and may be relied on by institutional investment managers filing Form 13F reports for the calendar quarter ending June 30, 2002. Institutional investment managers should report holdings- -number of shares and fair market value--as of the rast day of the calendar quarter as required by [ Section 13(f)(l) and Rule 13f-I] thereunder. Features (1) Additions and Deletions: Revisions made to the list of Section 13(f) securities are indicated in a column titled "STATUS." The word "ADDED" in the status column opposite the name of a security indicates that the security has become a Section 13(f) security. The word "DELETED" in the status column opposite the name of a security indicates that the security ceases to be a 13(f) security since the date of the last list. (2) List of options: An asterisk is placed next to the name of any security having a listed option and each option is individually listed with its own CUSlP number immediately below the name of the security having the option.
    [Show full text]